Significant growth expected in ion-exchange HPLC and immunoassay segments

Hemoglobin A1C (HbA1C) testing market

DUBLIN, March 15, 2024 (Globe Newswire) — The “Hemoglobin A1C (HbA1C) Testing – Global Strategic Business Report” report has been added. ResearchAndMarkets.com Recruitment.

Global market dynamics
The global hemoglobin A1C (HbA1C) testing market is on a solid growth trajectory, with the market size expected to reach USD 2.3 billion by 2030, the latest research publication reveals. This growth represents a stable compound annual growth rate (CAGR). Emphasis on diabetes management and enhanced accuracy of HbA1C testing methods are key drivers stimulating the expansion of this market.

segment analysis
The ion exchange high performance liquid chromatography (HPLC) sector has been identified as the main contributor to this growth and is expected to grow at a phenomenal CAGR of 7.6% to reach USD 915.7 million by 2030. I am. Advances in technology and the growing need for efficient diabetes monitoring tools led to a CAGR of 8.4%.

geographic insight
Intensified diagnostic efforts in the US puts it at the forefront of the HbA1C testing market, estimated at USD 397.5 million in 2022. Meanwhile, the Asia-Pacific region, led by China, is expected to grow rapidly at a staggering CAGR of 9.5%. This is due to the country's huge population and increasing healthcare investment. Japan and Canada are also expected to experience significant growth rates of 5.3% and 6.8%, respectively, during the forecast period. In Europe, Germany stands out with her CAGR of approximately 5.6%.

Competitive environment and economic outlook
This report highlights 110 notable competitors, demonstrating a competitive market environment where innovation and strategic collaboration are paramount. The global economy is showing signs of recovery, with GDP growth expected in various regions, led by economic powers such as the United States, the Eurozone, and China. The Indian market is particularly noteworthy, with the potential to become a $1 trillion economy by 2030, larger than Japan or Germany.

story continues

Additional report highlights

• Analysis of global economic conditions and market sentiment.

• Exploring global competitiveness with insights on key competitors' market shares.

• Market presence analysis across diverse geographies.

• Peer-to-peer collaboration for tailored updates and access to our digital archive.

This landmark report is intended to serve as an authoritative guide for healthcare industry stakeholders, investors, and decision makers, providing a comprehensive analysis of current market trends as well as the future in HbA1C testing. You will also have a clear understanding of the market opportunities. domain.

key attributes

Market trends and drivers

• Increased prevalence of diabetes: The rising prevalence of diabetes worldwide has increased the demand for HbA1c monitoring devices, which play an important role in diabetes management.

• Nearby patient testing: Close-to-patient testing is growing in popularity, benefiting the HbA1c device market by providing patients with a quick and convenient testing option.

• Point-of-care (POC) testing: Point-of-care HbA1c testing products offer several advantages over laboratory-based tests and are widely adopted by healthcare providers and patients.

• High risk in an aging demographic: The elderly, especially the population over 65 years of age, are at higher risk of diabetes, and there is an expected opportunity for growth in HbA1c testing devices.

• Increased obesity levels: Obesity is a significant risk factor for diabetes, contributing to the growth of the HbA1c monitoring devices market as healthcare systems seek effective ways to manage and monitor diabetic conditions.

• Increase in medical costs: Medical costs are increasing worldwide due to factors such as the increase in chronic diseases such as diabetes, and the demand for HbA1c testing devices is increasing.

• Early diagnosis and screening: Hemoglobin A1c testing is essential for early diagnosis of diabetes and plays an important role in screening strategies for conditions such as gestational diabetes.

• Technology development: Continuing advances in technology, such as the development of non-invasive blood glucose meters and continuous blood glucose monitors, are transforming diagnostics in diabetes care and providing alternatives to traditional HbA1c monitoring.

• Role in chronic disease: HbA1c monitoring is important in the management of chronic diseases such as chronic kidney disease, and diabetes management is essential to patient outcomes.

• Home testing market: The home HbA1c testing market is growing in response to the growing demand for convenient and accessible monitoring solutions for people with diabetes.

Some of the companies mentioned in this report include:

• Abbott Laboratories, Inc.

• beckman coulter company

• Bio-Rad Laboratories, Inc.

• Akon Laboratories Co., Ltd.

• ARKRAY Co., Ltd.

• A. Menarini Diagnostics Srl

• Apex Biotechnology Co., Ltd.

• Axis Shield Diagnostics Co., Ltd.

• Agappe Diagnostics Co., Ltd.

• Biolex Diagnostics

• Body Tech Med Co., Ltd.

• Biosurfit SA

• Acruex Biomedical Co., Ltd.

• Ilex Technology Group Co., Ltd.

• American Screening Corporation, Inc.

For more information on this report, please visit https://www.researchandmarkets.com/r/w7lu0n.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900